Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technosphere Insulin plus basal insulin versus premixed insulin in adults with type 2 diabetes
2006-000305-35Phase 3Completed
- Sponsor
- MannKind
- Start
- Apr 2006
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Technosphere insulin, insulin glargine and biphasic insulin aspart in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by MannKind. Primary endpoint: Change from baseline in HbA1c at Week 52. Started Apr 2006; status: completed.
02
Drugs
Technosphere insulininsulin glarginebiphasic insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-000305-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000305-35.